Saphnelo OverviewAnifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus (SLE). It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. ‹The template below is included via a redirect (Template:Mcn) that has been nominated for discussion. See redirects for discussion to help reach a consensus on what to do.›...
Read more Saphnelo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Anifrolumab
Recent Saphnelo Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 300mg/2ml(150mg/ml)
NDC Database Records for Saphnelo: (1 result)Sorted by National Drug Code
- 0310-3040 Saphnelo 300 mg/2ml Intravenous Injection, Solution by Astrazeneca Pharmaceuticals Lp